Application no. and date | 00965906.1 (espacenet) (Federated) (European Patent Register), 20000830 | Patent/reg. no. and date | DK/EP 1216038, 20050907 | Publication date | 20020626 | Priority no. and date | US 151436 P, 19990830 | EP pub. no. and date |
EP 1216038 20020626 | Effective date | | Applicant/owner | Sanofi-Aventis Deutschland GmbH, Brüningstrasse 50
D-65926 Frankfurt am Main, DE | Applicant ref. no. | | Inventor | BENDER, Norbert, Rheingaustrasse 28
65719 Hofheim, DE, YUSUF, Salim, 48 Woodend Drive
Carlisle, Ontario L0R 1H2, CA, Gerstein, Hertzel, 5 Dromore Crescent
Hamilton, Ontario L8S 4A8, CA | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 31/00 (2006.01) , A61K 31/403 (2006.01) , A61P 43/00 (2006.01) , A61P 9/00 (2006.01) , A61P 9/04 (2006.01) , A61P 9/10 (2006.01) , A61P 9/12 (2006.01) | Title | Anvendelse af inhibitorer af reninangiotensinsystemet ved forebyggelsen af cardiovaskulære hændelser | Int. application no. | EP2000008461 | Int. publication no. | WO2001015674 | Related patent (certificate) | | Status | Ophævet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|